360 related articles for article (PubMed ID: 10351640)
1. Drugs: budget busters or cost cutters in future health care?
Egger E
Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
[No Abstract] [Full Text] [Related]
2. Forecasting the future.
Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
[No Abstract] [Full Text] [Related]
3. Who's really raising drug prices?
Zagorin A
Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
[No Abstract] [Full Text] [Related]
4. Employers push to manage prescription drug costs.
Frieden J
Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
[No Abstract] [Full Text] [Related]
5. Why drugs cost so much.
Noonan D
Newsweek; 2000 Sep; 136(13):22-30. PubMed ID: 11183315
[No Abstract] [Full Text] [Related]
6. Rx for investors.
Stires D
Fortune; 2004 May; 149(9):158-60, 162, 164 passim. PubMed ID: 15124332
[No Abstract] [Full Text] [Related]
7. A few specialty drug prices fall--all generics.
Manag Care; 2008 Dec; 17(12):46. PubMed ID: 19127766
[No Abstract] [Full Text] [Related]
8. A behind-the-numbers look at rising Rx costs.
McCarthy R
Bus Health; 1998 Feb; 16(2):29, 32-5. PubMed ID: 10177023
[TBL] [Abstract][Full Text] [Related]
9. Don't pay too much for generic fills. Pass-through pricing is a good way for a payer to realize the benefit of increased prescribing of generic drugs.
Cahn LJ
Manag Care; 2010 Nov; 19(11):21-7. PubMed ID: 21141372
[No Abstract] [Full Text] [Related]
10. Generic drugs: the stalling game.
Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
[TBL] [Abstract][Full Text] [Related]
11. States combat drug costs.
Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
[No Abstract] [Full Text] [Related]
12. Limited options to manage specialty drug spending.
Tu HT; Samuel DR
Res Brief; 2012 Apr; (22):1-13. PubMed ID: 23155549
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical industry.
Lewis L
State Health Care Am; 1994; ():23-7. PubMed ID: 10133845
[TBL] [Abstract][Full Text] [Related]
14. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
15. The latest trends in the pharmaceutical market.
Teitelbaum F
Case Manager; 2000; 11(5):70-4. PubMed ID: 11935588
[No Abstract] [Full Text] [Related]
16. The cost of prescription drugs: rising concerns over equity, fairness and access to essential care.
Work DR; Domino ME
N C Med J; 2003; 64(6):270-4. PubMed ID: 14983614
[No Abstract] [Full Text] [Related]
17. Medicine and the pharmaceutical industry: what's right, what's wrong, and what's to come.
Tan SY
Singapore Med J; 1998 Mar; 39(3):91-5. PubMed ID: 9632964
[No Abstract] [Full Text] [Related]
18. Increased direct-to-consumer advertising driving pharmaceutical costs, trends.
Fine A
Exec Solut Healthc Manag; 1999 Jan; 2(1):2-3. PubMed ID: 10345986
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
Seay M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
[No Abstract] [Full Text] [Related]
20. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?
Pavenik N
Rand J Econ; 2002; 33(3):469-87. PubMed ID: 12585303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
